← Eichor
Study identifier: NCT05917301 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pre-operative Hypofractionated Proton Therapy

Condition: Soft Tissue Sarcoma  ·  Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is being done to examine whether proton therapy for certain kinds of sarcomas (extremity and trunk soft tissue) is safe and effective. As part of the study, patients will have five fractions of proton therapy before the participants have surgery for the sarcoma. The study will measure wound complications and functional outcomes / quality of life after the procedures. Patients will be asked to complete questionnaires about the treatment and quality of life from the time of enrollment until about two years after surgery. Otherwise, the participants will have standard of care follow ups with the treatment team.

This description comes directly from the study's public registry record.

Talk to the study team

Curtiland Deville, MD  ·  202-537-4788  ·  cdeville@jhmi.edu

Ryan Manuel  ·  rmanuel5@jhmi.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Sibley Memorial HospitalWashington D.C., District of Columbia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05917301